Johnny Mahlangu to Healthy Volunteers
This is a "connection" page, showing publications Johnny Mahlangu has written about Healthy Volunteers.
Connection Strength
0,124
-
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. J Thromb Haemost. 2015 May; 13(5):743-54.
Score: 0,124